SCHEMBL8224388

SCHEMBL8224388

COCC1CC(C(=O)O)CCN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.48
▸ POLB P06746 1/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ PAX8 Q06710 1/20 0.46
▸ MMP1 P03956 2/20 0.44
▸ ADAM17 P78536 2/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TSHR P16473 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ CASP3 P42574 2/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ CASP9 P55211 1/20 0.43
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6518007 1.00 ALDH1A1 (0.48) ALDH1A1POLBRAB9APAX8MMP1
SCHEMBL6522988 1.00 ALDH1A1 (0.48) ALDH1A1POLBRAB9APAX8MMP1
SCHEMBL8219313 0.87 POLB (0.49) ALDH1A1POLBRAB9APAX8KMT2A
SCHEMBL6518443 0.87 POLB (0.49) ALDH1A1POLBRAB9APAX8KMT2A
SCHEMBL6523714 0.87 POLB (0.49) ALDH1A1POLBRAB9APAX8KMT2A
SCHEMBL15013036 0.79 CASP3 (0.64) RAB9APAX8CASP3CASP7CASP9
SCHEMBL12169307 0.79 CASP3 (0.64) RAB9APAX8CASP3CASP7CASP9
SCHEMBL15013035 0.79 CASP3 (0.64) RAB9APAX8CASP3CASP7CASP9
SCHEMBL12085003 0.78 EPHX2 (0.56) ALDH1A1POLBRAB9APAX8KMT2A
SCHEMBL12084999 0.78 EPHX2 (0.56) ALDH1A1POLBRAB9APAX8KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2475644-A1 HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-07-18 — — EP disclosed
WO-2011029808-A1 HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-03-17 — — WO disclosed
Send feedback